Benzinga | Jul 30, 2020 04:18PM EDT

Anika Therapeutics Q2 EPS $(0.54) Misses $(0.24) Estimate, Sales $30.70M Beat $20.37M Estimate

Anika Therapeutics (NASDAQ:ANIK) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.24) by 125 percent. This is a 180.6 percent decrease over earnings of $0.67 per share from the same period last year. The company reported quarterly sales of $30.70 million which beat the analyst consensus estimate of $20.37 million by 50.71 percent. This is a 0.93 percent increase over sales of $30.42 million the same period last year.